Long-term effects of postnatal corticosteroids to prevent or treat bronchopulmonary dysplasia: Balancing the risks and benefits

Doyle, 2017, Ventilation in extremely preterm infants and respiratory function at 8 years, N Engl J Med, 377, 329, 10.1056/NEJMoa1700827 Costeloe, 2012, Short term outcomes after extreme preterm birth in England: comparison of two birth cohorts in 1995 and 2006 (the EPICure studies), BMJ, 345, 10.1136/bmj.e7976 Younge, 2017, Survival and neurodevelopmental outcomes among periviable infants, N Engl J Med, 376, 617, 10.1056/NEJMoa1605566 Jobe, 2001, Bronchopulmonary dysplasia, Am J Respir Crit Care Med, 163, 1723, 10.1164/ajrccm.163.7.2011060 Rhen, 2005, Antiinflammatory action of glucocorticoids--new mechanisms for old drugs, N Engl J Med, 353, 1711, 10.1056/NEJMra050541 Watterberg, 2010, Postnatal corticosteroids to prevent or treat bronchopulmonary dysplasia, Pediatrics, 126, 800, 10.1542/peds.2010-1534 Watterberg, 2012, Evidence-based neonatal pharmacotherapy: postnatal corticosteroids, Clin Perinatol, 39, 47, 10.1016/j.clp.2011.12.017 Meikle, 1977, Potency and duration of action of glucocorticoids. Effects of hydrocortisone, prednisone and dexamethasone on human pituitary-adrenal function, Am J Med, 63, 200, 10.1016/0002-9343(77)90233-9 McEwen, 1997, The brain is an important target of adrenal steroid actions. A comparison of synthetic and natural steroids, Ann N Y Acad Sci, 823, 201, 10.1111/j.1749-6632.1997.tb48392.x Doyle, 2017, Early (< 8 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants, Cochrane Database Syst Rev, 10, Cd001146 Doyle, 2017, Late (> 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants, Cochrane Database Syst Rev, 10, Cd001145 Cummings, 1989, A controlled trial of dexamethasone in preterm infants at high risk for bronchopulmonary dysplasia, N Engl J Med, 320, 1505, 10.1056/NEJM198906083202301 Yeh, 2004, Outcomes at school age after postnatal dexamethasone therapy for lung disease of prematurity, N Engl J Med, 350, 1304, 10.1056/NEJMoa032089 Yeh, 1997, Early postnatal dexamethasone therapy for the prevention of chronic lung disease in preterm infants with respiratory distress syndrome: a multicenter clinical trial, Pediatrics, 100, E3, 10.1542/peds.100.4.e3 American Academy of Pediatrics, 2002, Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants, Pediatrics, 109, 330, 10.1542/peds.109.2.330 Barrington, 2001, Hazards of systemic steroids for ventilator-dependent preterm infants: what would a parent want?, CMAJ (Can Med Assoc J), 165, 33 Doyle, 2006, Low-dose dexamethasone facilitates extubation among chronically ventilator-dependent infants: a multicenter, international, randomized, controlled trial, Pediatrics, 117, 75, 10.1542/peds.2004-2843 Doyle, 2014, An update on the impact of postnatal systemic corticosteroids on mortality and cerebral palsy in preterm infants: effect modification by risk of bronchopulmonary dysplasia, J Pediatr, 165, 1258, 10.1016/j.jpeds.2014.07.049 Cheong, 2013, Postnatal corticosteroids and neurodevelopmental outcomes in extremely low birthweight or extremely preterm infants: 15-year experience in Victoria, Australia, Arch Dis Child Fetal Neonatal Ed, 98, F32, 10.1136/fetalneonatal-2011-301355 Walsh, 2006, Changes in the use of postnatal steroids for bronchopulmonary dysplasia in 3 large neonatal networks, Pediatrics, 118, e1328, 10.1542/peds.2006-0359 Stark, 2014, Death or neurodevelopmental impairment at 18 to 22 months corrected age in a randomized trial of early dexamethasone to prevent death or chronic lung disease in extremely low birth weight infants, J Pediatr, 164, 10.1016/j.jpeds.2013.07.027 Baud, 2016, Effect of early low-dose hydrocortisone on survival without bronchopulmonary dysplasia in extremely preterm infants (PREMILOC): a double-blind, placebo-controlled, multicentre, randomised trial, Lancet, 387, 1827, 10.1016/S0140-6736(16)00202-6 Yeh, 2016, Intratracheal administration of budesonide/surfactant to prevent bronchopulmonary dysplasia, Am J Respir Crit Care Med, 193, 86, 10.1164/rccm.201505-0861OC Bassler, 2015, Early inhaled budesonide for the prevention of bronchopulmonary dysplasia, N Engl J Med, 373, 1497, 10.1056/NEJMoa1501917 Onland, 2017, Late (>/= 7 days) inhalation corticosteroids to reduce bronchopulmonary dysplasia in preterm infants, Cochrane Database Syst Rev, 8, Cd002311 Shah, 2017, Early administration of inhaled corticosteroids for preventing chronic lung disease in very low birth weight preterm neonates, Cochrane Database Syst Rev, 1, Cd001969 Bassler, 2015, Early inhaled budesonide for the prevention of bronchopulmonary dysplasia, N Engl J Med, 373, 1497, 10.1056/NEJMoa1501917 Jangaard, 2002, Early prophylactic inhaled beclomethasone in infants less than 1250 g for the prevention of chronic lung disease, Paediatr Child Health, 7, 13, 10.1093/pch/7.1.13 Nakamura, 2016, Early inhaled steroid use in extremely low birthweight infants: a randomised controlled trial, Arch Dis Child Fetal Neonatal Ed, 10.1136/archdischild-2015-309943 Bassler, 2018, Long-term effects of inhaled budesonide for bronchopulmonary dysplasia, N Engl J Med, 378, 148, 10.1056/NEJMoa1708831 Venkataraman, 2017, Intratracheal administration of budesonide-surfactant in prevention of bronchopulmonary dysplasia in very low birth weight infants: a systematic review and meta-analysis, Pediatr Pulmonol, 52, 968, 10.1002/ppul.23680 Yeh, 2008, Early intratracheal instillation of budesonide using surfactant as a vehicle to prevent chronic lung disease in preterm infants: a pilot study, Pediatrics, 121, e1310, 10.1542/peds.2007-1973 Onland, 2011, Systemic hydrocortisone to prevent bronchopulmonary dysplasia in preterm infants (the SToP-BPD study); a multicenter randomized placebo controlled trial, BMC Pediatr, 11, 102, 10.1186/1471-2431-11-102 Onland, 2019, Effect of hydrocortisone therapy initiated 7 to 14 days after birth on mortality or bronchopulmonary dysplasia among very preterm infants receiving mechanical ventilation: a randomized clinical trial, J Am Med Assoc, 321, 354, 10.1001/jama.2018.21443 Halliday, 2001, A multicenter, randomized open study of early corticosteroid treatment (OSECT) in preterm infants with respiratory illness: comparison of early and late treatment and of dexamethasone and inhaled budesonide, Pediatrics, 107, 232, 10.1542/peds.107.2.232 Shah, 2017, Inhaled versus systemic corticosteroids for preventing bronchopulmonary dysplasia in ventilated very low birth weight preterm neonates, Cochrane Database Syst Rev, 10 Shah, 2017, Inhaled versus systemic corticosteroids for the treatment of bronchopulmonary dysplasia in ventilated very low birth weight preterm infants, Cochrane Database Syst Rev, 10